US WorldMeds CNS Portfolio

Quote












45 mil in profit per year from the 3 current products. So we pay 300 mil (up to 500 mil) for that plus a 4th that may see approval in late 2021. With my MBA I can tell you we overpaid. Seems like 4 ok products and none of them will touch txr in terms of sales.
 






You deserve a full refund on whatever out of pocket expenses you incurred while in pursuit of that degree. You clearly took nothing worthwhile away. But hey, you are a sales rep so you likely already figured that out
 






anonymous said:
45 mil in profit per year from the 3 current products. So we pay 300 mil (up to 500 mil) for that plus a 4th that may see approval in late 2021. With my MBA I can tell you we overpaid. Seems like 4 ok products and none of them will touch txr in terms of sales.
Click to expand...

You are so out of touch!!! You are probably some rep that jumped ship! This is HUGE for our company! Apokyn has like 4 years left on their patent. The other 2 are killer too! Oh my god we waited for 7 years how could our upper management buy anything less than blockbuster products!
 












  • US WorldMeds’ CNS portfolio consists of three marketed products with 2019 net sales of approximately $150 million. With the product portfolio comes an experienced team including a proven salesforce and a medical organization with expertise and focus on serving movement disorder specialists in the U.S.
Experienced team including a proven sales force. Nothing else to see here!
 






what the... deal comes with their own sales force. Been working my ass off for about 8 years and we buy something that includes the salespeople? That’s how much the company cares about the group of go getters that sold the shit out of TXR and OXR. Maybe it’s good for the company but what does it do for your current sales force?
 






Current sales force is going to ADHD. Wtf is wrong with you? Things an entire additional division that will be filled with opportunities. Food chance will be launching another product next year. You people can’t even wait 5 minutes before you assertively pronounce your opinion as fact? Bunch of children playing adult
 






anonymous said:
what the... deal comes with their own sales force. Been working my ass off for about 8 years and we buy something that includes the salespeople? That’s how much the company cares about the group of go getters that sold the shit out of TXR and OXR. Maybe it’s good for the company but what does it do for your current sales force?
Click to expand...

I feel the same to a degree. I thought we were getting a new drug in our bag to sell....nope. now there will be 2 supernus reps going into the same office.
 






anonymous said:
what the... deal comes with their own sales force. Been working my ass off for about 8 years and we buy something that includes the salespeople? That’s how much the company cares about the group of go getters that sold the shit out of TXR and OXR. Maybe it’s good for the company but what does it do for your current sales force?
Click to expand...

So let me get a handle on the logic here...if we buy a pipeline candidate, it’s too far out and therefore a bad deal. If we buy 3 marketed products and a late stage, but they have a sales force therefore it’s a bad deal. Sounds like to make you happy we should only buy marketed products not actively being promoted by a salesforce...because that’s a sign of a healthy business.
 












anonymous said:
I feel the same to a degree. I thought we were getting a new drug in our bag to sell....nope. now there will be 2 supernus reps going into the same office.
Click to expand...

Are you guys for real? It’s starting to sound like the only thing that would make you happy is adding a miracle cure for cancer to your bag. Be realistic. You joined a start up XR company that is about to launch into adhd and just made acquisitions that add a promising depression drug and 3 real CNS products that may not be blockbusters but still pull in revenue. ALL DURING A GLOBAL PANDEMIC WHILE MILLIONS HAVE LOST THEIR JOBS AND SOME THEIR LIVES. Have some GD self awareness.
 






Went into self quarantine with 2 approved and 3 pipeline products and coming out with 5 approved and 5 pipeline. I can sleep tonight knowing the grass isn’t greener on the other side and this company means what they say. 2019 fumble or not, I’ve never been prouder to be a small part of this organization. Thanks Jack!
 






anonymous said:
45 mil in profit per year from the 3 current products. So we pay 300 mil (up to 500 mil) for that plus a 4th that may see approval in late 2021. With my MBA I can tell you we overpaid. Seems like 4 ok products and none of them will touch txr in terms of sales.
Click to expand...

Yes we have done pretty well with txr. Thank you for the unintended complement.
 






anonymous said:
Current sales force is going to ADHD. Wtf is wrong with you? Things an entire additional division that will be filled with opportunities. Food chance will be launching another product next year. You people can’t even wait 5 minutes before you assertively pronounce your opinion as fact? Bunch of children playing adult
Click to expand...

Nothing wrong with me thanks for asking. Go drink your koolaid and chill the f out. Surprised you didn’t tell me to dust off my resume as that is a common response. You are clearly not a rep who gets paid on selling products. Nothing is 100% on anyone going to adhd. As a sales rep in this industry it’s what is in your bag now. Now fill your glass back up.
 






anonymous said:
Yes we have done pretty well with txr. Thank you for the unintended complement.
Click to expand...

400 mil in sales is nothing to sneeze at. And I am proud of being a part of that. But these 3 products....are lets see....1 is generic, 1 has a year left, the last has 4 years left. Us worldmeds dumped their dying CNS profile...doesn't take a rocket scientist to figure this out. Why do you think all the bigger neuro companies passed?
 






anonymous said:
400 mil in sales is nothing to sneeze at. And I am proud of being a part of that. But these 3 products....are lets see....1 is generic, 1 has a year left, the last has 4 years left. Us worldmeds dumped their dying CNS profile...doesn't take a rocket scientist to figure this out. Why do you think all the bigger neuro companies passed?
Click to expand...

I'm happy that we were the company that purchased and not the company that was purchased. You have to agree with that right?
 






anonymous said:
400 mil in sales is nothing to sneeze at. And I am proud of being a part of that. But these 3 products....are lets see....1 is generic, 1 has a year left, the last has 4 years left. Us worldmeds dumped their dying CNS profile...doesn't take a rocket scientist to figure this out. Why do you think all the bigger neuro companies passed?
Click to expand...

What do you think is available to buy that’s better?
 






It’s not so much that you naysayers lack the information or experience to assess this deal, it’s that you believe you do.

This is a huge deal for our company. This gets us into orphan, small molecule, buy & bill, and specialty pharmacies. This also makes us much more attractive partners to companies with the “blockbuster” you children keep crying for.

Those who have already decided this represents “no opportunity” for our existing team have obviously never been through a buyout before and seen how it really goes down.

So, you can either 1)fly off the handle 5 minutes after the press release and believe somehow you know why you are talking about, or 2) wait for it to play out And see how wrong you are (yet again) or, if you really believe things are half as bad as you claim, 3) leave.

Makes no difference either way, we don’t need you (which I know crushes your delicate, self-important psyche)
 






Top Bottom
Back
Quote